Janumet Tablet, Film Coated, Extended Release
Product Images NDC 0006-0078

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Janumet (NDC 0006-0078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Sitagliptin Chemical Structure (Janumetxr 01)

Chemical structure of sitagliptin depicted with its molecular components, including carbon, nitrogen, oxygen, fluorine atoms, and associated phosphate and water molecules.*

FDA Label Image

Image Of Metaformin Chemical Structure (Janumetxr 02)

Chemical structure of sitagliptin, an active ingredient in JANUMET XR tablets containing sitagliptin and metformin hydrochloride. The structure shows key functional groups and the hydrochloride (HCl) component.*

FDA Label Image

Image Of Figure 1 (Janumetxr 03)

Line graph showing LS mean change from baseline over 24 weeks comparing placebo and various doses of sitagliptin and metformin immediate-release. The x-axis represents weeks (0 to 24) and the y-axis shows LS mean change from baseline. Multiple treatment groups are plotted, including placebo, sitagliptin 100 mg once daily, metformin 500 mg and 1000 mg twice daily, and combinations of sitagliptin 50 mg twice daily with metformin 500 mg or 1000 mg twice daily.*

FDA Label Image

Image Of Figure 2 (Janumetxr 04)

A line graph comparing the least squares mean change from baseline over 52 weeks for Sitagliptin 100 mg and Glipizide. The x-axis represents time in weeks, and the y-axis shows the LS mean change from baseline. Both lines show a similar trend in change over the study period.*

FDA Label Image

Principal Display Panel (50 mg/500 mg Tablet Bottle Label)

Label for JANUMET XR (sitagliptin and metformin hydrochloride extended-release) tablets, 50 mg/500 mg strength. The label shows an image of a film-coated, extended-release tablet marked with '78.' It indicates a prescription drug, bottle containing 60 tablets, and is labeled by Merck Sharp & Dohme LLC. Storage instructions and NDC 0006-0078-61 are visible.*

FDA Label Image

Principal Display Panel (50 mg/1,000 mg Tablet Bottle Label)

Label for JANUMET XR (sitagliptin and metformin HCl extended-release) tablets, showing strength 50 mg / 1,000 mg. The label includes drug name, active ingredients, dosage form as extended-release film-coated tablets, quantity of 60 tablets, and a photo of an oval white tablet imprinted with '80'. Manufacturer is Merck Sharp & Dohme LLC.*

FDA Label Image

Principal Display Panel (100 mg/1,000 mg Tablet Bottle Label)

Janumet XR (sitagliptin and metformin HCl extended-release) tablets 100 mg / 1,000 mg in oral tablet form. The white label shows the brand and generic names along with dosage strength. It contains 30 film-coated extended-release tablets and is labeled for prescription use only. Manufacturer is Merck Sharp & Dohme LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.